Navigation Links
First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment
Date:2/11/2013

The new study published in Cancer Discovery, the flagship journal of the American Association of Cancer Research (AACR), involving three Spanish and six American research centres, presents significant results in treating cancer patients with nanoparticles containing ribonucleic acid interference (RNAi) molecules. This marks the first time that the therapeutic effect of RNAi has been demonstrated in humans.

Barcelona, 11 February 2013. A study led by Dr Josep Tabernero, the Director of Clinical Research at the Vall d'Hebron Institute of Oncology (VHIO) and Head of the Medical Oncology Department at the Vall d'Hebron University Hospital, shows for the first time that ribonucleic acid interference (RNAi) is effective in the treatment of cancer patients. Harnessing these molecules to silence genes involved in the development and growth of cancer cells is an important step forward in developing a new and more targeted type of cancer therapy.

Dr Josep Tabernero, lead author of this study, said: "This is the first evidence to show that RNAi can be administered to cancer patients effectively, leading to significant tumour response."

RNAi is a gene-silencing mechanism that uses a subtype of RNA molecules to interfere with and silence genes. RNAi plays a vital role in normal cell development and differentiation, in cancer and viral defence, as it is powerful mechanism in the regulation of gene expression. Besides being a key natural cellular phenomenon, gene silencing shows great potential as a therapeutic device to shut down genes that have become hyperactive through cancer.

However, researchers have encountered difficulties in administering RNAi, as the molecules must penetrate cells in therapeutically effective concentrations, which in turn requires structural modifications. In the new study, led by the Vall d'Hebron Institute of Oncology (VHIO), along with several other cancer research centres and the U.S. biotech comp
'/>"/>

Contact: Amanda Wren
awren@vhio.net
34-695-207-886
Vall dHebron Institute of Oncology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Studying bed bug actions for new management tactics
2. Study identifies liver gene that regulates cholesterol and fat blood levels
3. Study shows disease spread in ladybirds with sexually transmitted disease
4. Nitrogen from pollution, natural sources causes growth of toxic algae, study finds
5. Study of a rare disease making people look like a woman but having male genitals under study
6. Study finds potential to match tumors with known cancer drugs
7. Can plants be altruistic? You bet, says new CU-Boulder-led study
8. New study sheds light on link between dairy intake and bone health
9. Medical societies to launch large-scale study on vein filter use
10. Virginia Tech adjunct and colleagues refute a study on racial bias report in NIH awards
11. Researcher uncovers potential cause, biomarker for autism and proposes study to investigate theory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
(Date:3/17/2015)... YORK , March 17, 2015  MecklerMedia ... the largest exhibition for service robots ever held ... RoboUniverse takes place on May 11-13, 2015 at ... and exhibitors for the event include: Acorn Product ... Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; ...
(Date:3/12/2015)... 2015 IriTech, a leading iris based identity ... Texas Instruments Design Network, announced today that the Chief ... IriShield USB MK2120U device during a launching event of ... The iris scanner is manufactured by ... India through its Indian partner, ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3
... SAN FRANCISCO, FEB. 10, 2011 -- Research presented today ... Medicine (SMFM) -- The Pregnancy Meeting has found that three ... part for the success of progesterone treatments in the prevention ... role in triggering normal labor. The proteins ...
... that we know everything about how the flea jumps, ... store the energy needed to catapult themselves into the ... in the intervening years debate raged about exactly how ... came up with competing hypotheses, but neither had access ...
... groups of lowly marine worms are related to complex species ... research. Previously thought to be an evolutionary link between simple ... - the worms, surprising promotion implies that they have not ... the marine worms Xenoturbella and Acoelomorpha ...
Cached Biology News:New research helps explain how progesterone prevents preterm birth 244-year-old mystery of how fleas jump resolved 244-year-old mystery of how fleas jump resolved 3Simple marine worms distantly related to humans 2
(Date:4/16/2015)... South San Francisco, CA (PRWEB) April 16, 2015 ... it is scheduled to report first quarter results on ... Following the announcement, Cytokinetics’ senior management will host a ... operational and financial results and the company’s outlook for ... webcast and can be accessed from the homepage and ...
(Date:4/16/2015)...  Schulman Associates IRB, Inc., the industry-leading central IRB ... lease on Laboratory Drive in the heart of ... location will house review board and service staff, which ... and customer service to clients. CBRE ... the deal, while Capital Associates Management, LLC represented the ...
(Date:4/16/2015)... April 16, 2015 OncoTAb, ... Charlotte (UNC Charlotte) spin-out company, announced today the ... Ph.D., M.D., as Chief Operating Officer (COO). Cooper ... experience in developing clinical diagnostic and biotechnology platforms ... disease. , Cooper’s extensive career transcends the field ...
(Date:4/16/2015)... Portage Biotech Inc. ("Portage" or "the Company" )) (OTC ... announce that the Company will be presenting  at the ... held in London, UK . Portage,s ... James Mellon , a director of Portage, will provide ... at its subsidiaries, Portage Pharmaceuticals Ltd. ("PPL"), and Biohaven ...
Breaking Biology Technology:Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3Schulman IRB to Open Office in Research Triangle Park, N.C. 2OncoTAb Names Dr. David L. Cooper as COO 2Portage to Present at Master Investor 2015 in London, UK 2Portage to Present at Master Investor 2015 in London, UK 3Portage to Present at Master Investor 2015 in London, UK 4
... 29, 2009 Very tiny wires, called nanowires, made from ... crucial role as electrical or mechanical switches in the ... will require a deep understanding of how these and ... as their resultant strengths and weaknesses. How mechanical ...
... Incorporated (Nasdaq: VPHM ) today announced that the ... conferences. , Vincent Milano, president and chief executive ... Annual Healthcare Conference at 4:30 P.M. EST on Tuesday, ... at the Waldorf=Astoria in New York City. , Charles ...
... Novavax, Inc. (Nasdaq: NVAX ) a clinical-stage vaccine company, ... Officer, will be presenting at the Oppenheimer 20th Annual Healthcare ... 3:20 pm local time on November 3, 2009 at ... an overview of the company,s business strategy and research and ...
Cached Biology Technology:LANL Roadrunner simulates nanoscale material failure 2ViroPharma to Present at Three November Healthcare Conferences 2NOVAVAX to Present at Oppenheimer 20th Annual Healthcare Conference 2
... the research-grade spectrofluorometer with a minimum 1 ... ratio 200 or greater for the Raman ... designed to keep in mind in order ... stopped-flow, titration, or anisotropic measurements. ,The FP-6500 ...
... for genome-wide microRNA expression profiling and ... Paraflo microfluidic on-chip synthesis platform. These ... our comprehensive microRNA Expression Profiling Service. ... Fishes microRNA Microarray contains all known ...
... Microarrays designed for genome-wide microRNA expression ... and powerful Paraflo microfluidic on-chip synthesis ... part of our comprehensive microRNA Expression ... The Viruses microRNA Microarray contains ...
... The LTQ XL extends the legendary MSn ... to generate structural information through Thermo Scientifics ... Scientific's LTQ XL is the only mass ... ETD and CID. Pulsed Q Collision ...
Biology Products: